News about Global Pharma

US FDA Approves Abbvie's EMBLAVEO

AbbVie announced that the US Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic.

Global Pharma | 10/02/2025 | By Manvi |  709

BioRay's ROR1-Targeting Dual-Epitope ADC BR111 Gains NMPA Clinical Trial Approval

BioRay Pharmaceutical announced that China's NMPA has accepted the clinical trial application for BR111, a first-in-class bi-paratopic ADC targeting ROR1 for the treatment of hematological malignancies and solid tumours.

Global Pharma | 10/02/2025 | By Manvi |  451

Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore

The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.

Global Pharma | 10/02/2025 | By Aishwarya |  1286

Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation

As an independent company, Tanabe Pharma will continue to build on its legacy of medical innovation while developing new opportunities for growth through business development, licensing activities, enhanced R&D productivity, commercialization and strategic acquisitions.

Global Pharma | 10/02/2025 | By Aishwarya |  509

ClariMed Opens its Advanced Simulated Use Research Center in Cambridge, UK

The new purpose-built facility features innovative design elements that enhance the quality and scope of human factors studies, including a dedicated observation area on the second floor that provides unparalleled visibility of participant interactions.

Global Pharma | 07/02/2025 | By Manvi |  253

Delta Development Team Launches its Cutting-Edge Tricon Refrigerated Containers

Delta Development Team, Inc (DDT) is pushing the boundaries of innovative storage and transport solutions for temperature-sensitive goods with the development of advanced, large-scale refrigerated Tricon containers.

Global Pharma | 07/02/2025 | By Manvi |  353

Aurobindo Pharma to Use Solar Power in Company's Operations to Promote Sustainability

Hyderabad-based Aurobindo Pharma has signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.

Global Pharma | 07/02/2025 | By Manvi |  886

Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval

The reference medicine golimumab has been approved in Europe for several indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.

Global Pharma | 07/02/2025 | By Abha |  579

Eli Lilly's Omvoh Shows Long-Term Efficacy in Crohn's Disease: VIVID-2 Study Results Announced

Omvoh works to reduce inflammation within the gastrointestinal tract by targeting a specific protein, interleukin-23p19 (IL-23p19), which is a key contributor to intestinal inflammation.

Global Pharma | 07/02/2025 | By Abha |  579

Astellas Submits NDA for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

Astellas Pharma has submitted a New Drug Application in Japan for avacincaptad pegol (ACP), a potential first-in-class treatment for geographic atrophy (GA) secondary to AMD, aiming to address a major unmet medical need.

Global Pharma | 06/02/2025 | By Manvi |  270